Comments
Loading...

Contineum Therapeutics

CTNMNASDAQ
Logo brought to you by Benzinga Data
$19.64
0.31.53%
At close: -
$19.63
-0.0050-0.03%
After Hours: 4:02 PM EDT
Q3 2024 Earnings were released on Wed Nov 6th, after the market close

Contineum Therapeutics (NASDAQ:CTNM) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for Contineum Therapeutics (CTNM)?

A

There have been no specific sales or earnings guidance reported for Contineum Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch